VCNX
Vaccinex Inc

5,536
Mkt Cap
$2.68M
Volume
79.00
52W High
$1.50
52W Low
$0.31
Price
$1.00
VCNX Fundamentals
Prev Close
$1.04
Open
$1.18
50D MA
$1.05
Beta
1.84
Avg. Volume
2,834.91
Loading...
Loading...

About

Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer in April 2001 and is headquartered in Rochester, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Vaccinex Inc?
What is the 52-week high for Vaccinex Inc?
What is the 52-week low for Vaccinex Inc?
What is Vaccinex Inc stock price today?
What was Vaccinex Inc stock price yesterday?
What is the 50-day moving average of Vaccinex Inc?

Latest VCNX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.